JP2008512374A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512374A5
JP2008512374A5 JP2007530388A JP2007530388A JP2008512374A5 JP 2008512374 A5 JP2008512374 A5 JP 2008512374A5 JP 2007530388 A JP2007530388 A JP 2007530388A JP 2007530388 A JP2007530388 A JP 2007530388A JP 2008512374 A5 JP2008512374 A5 JP 2008512374A5
Authority
JP
Japan
Prior art keywords
nhc
substituted
unsubstituted
lower alkyl
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007530388A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512374A (ja
Filing date
Publication date
Priority claimed from US10/934,974 external-priority patent/US7470723B2/en
Application filed filed Critical
Publication of JP2008512374A publication Critical patent/JP2008512374A/ja
Publication of JP2008512374A5 publication Critical patent/JP2008512374A5/ja
Pending legal-status Critical Current

Links

JP2007530388A 2004-09-03 2005-08-31 ジフェニルエチレン化合物及びその使用 Pending JP2008512374A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/934,974 US7470723B2 (en) 2003-03-05 2004-09-03 Diphenylethylene compounds and uses thereof
PCT/US2005/031282 WO2006026747A2 (en) 2004-09-03 2005-08-31 Diphenylethylene compounds and uses thereof

Publications (2)

Publication Number Publication Date
JP2008512374A JP2008512374A (ja) 2008-04-24
JP2008512374A5 true JP2008512374A5 (cg-RX-API-DMAC7.html) 2008-10-16

Family

ID=35740067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007530388A Pending JP2008512374A (ja) 2004-09-03 2005-08-31 ジフェニルエチレン化合物及びその使用

Country Status (12)

Country Link
US (1) US7470723B2 (cg-RX-API-DMAC7.html)
EP (1) EP1799634A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008512374A (cg-RX-API-DMAC7.html)
KR (1) KR20070061854A (cg-RX-API-DMAC7.html)
CN (1) CN101056846A (cg-RX-API-DMAC7.html)
AR (1) AR050558A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005279788A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0514890A (cg-RX-API-DMAC7.html)
CA (1) CA2578772A1 (cg-RX-API-DMAC7.html)
IL (1) IL181675A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007002525A (cg-RX-API-DMAC7.html)
WO (1) WO2006026747A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7470723B2 (en) 2003-03-05 2008-12-30 Celgene Corporation Diphenylethylene compounds and uses thereof
MXPA05009434A (es) * 2003-03-05 2005-11-23 Celgene Corp Compuestos de difeniletileno y usos de los mismos.
US20050142104A1 (en) * 2003-11-06 2005-06-30 Zeldis Jerome B. Methods of using and compositions comprising PDE4 modulators for the treatment and management of asbestos-related diseases and disorders
CN102772358A (zh) * 2005-06-16 2012-11-14 美瑞德生物工程公司 药物组合物及其用途
US8569356B2 (en) * 2005-10-25 2013-10-29 University Of Florida Research Foundation, Inc. Cyclin dependent kinase inhibitors
FR2914640B1 (fr) 2007-04-04 2012-11-16 Centre Nat Rech Scient Iso ca-4 et analogues : puissants cytotoxiques, inhibiteurs de polymerisation de la tubuline
CA2720989A1 (en) * 2007-04-10 2008-10-16 Myrexis, Inc. Methods for treating cancer
KR20100016385A (ko) * 2007-04-10 2010-02-12 미리어드 파마슈티칼스, 인코포레이티드 뇌종양 치료방법
EP2144887A4 (en) * 2007-04-10 2012-10-03 Myrexis Inc PHARMACEUTICAL FORMS AND METHOD FOR THE TREATMENT OF CANCER
WO2008124828A1 (en) * 2007-04-10 2008-10-16 Myriad Genetics, Inc. Methods for treating vascular disruption disorders
NZ580867A (en) * 2007-04-10 2011-02-25 Myriad Pharmaceuticals Inc Method of treating melanoma
FR2932180B1 (fr) * 2008-06-04 2012-08-10 Centre Nat Rech Scient Dihydro iso ca-4 et analogues : puissants cytotoxiques, inhibiteurs de la polymerisation de la tubuline
EP3288384A4 (en) * 2015-05-01 2019-01-23 Georgia State University Research Foundation BENZHYDROL DERIVATIVES FOR ADMINISTERING CONDITIONS RELATED TO HYPOXIC INDUCIBLE FACTORS
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
CN115624959B (zh) * 2022-09-30 2023-11-24 河南省尤里卡生物科技有限公司 一种尿激酶吸附材料及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3059021A (en) * 1960-02-12 1962-10-16 Monsanto Chemicals 1, 1, 1-trichloro-2, 2-bis[(carboalkoxy-amino) aryl] ethane
GR61627B (en) * 1975-08-28 1978-12-04 Lilly Co Eli Preparation process of carbonyl-substituted 1-sulfonylbenzimidazoles
US4420479A (en) 1982-04-08 1983-12-13 Eli Lilly And Company Olefinic benzimidazoles, formulations, and antiviral methods
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
JPS58188868A (ja) 1983-04-08 1983-11-04 イ−ライ・リリ−・アンド・カンパニ− オレフイン系ベンズイミダゾ−ル類
ZA88960B (en) * 1987-02-13 1988-08-15 Ciba-Geigy Ag. Diphenylethylene derivatives
ATE95176T1 (de) 1987-10-21 1993-10-15 Du Pont Merck Pharma Aminomethyl-oxo-oxazolidinyl-ethenylbenzenderivate, nuetzlich als antibakterielles mittel.
JPH0566591A (ja) 1991-09-10 1993-03-19 Canon Inc 電子写真感光体、該電子写真感光体を備えた電子写真装置並びにフアクシミリ
DE4220983A1 (de) * 1992-06-26 1994-01-05 Bayer Ag Imidazolyl-substituierte Phenylpropion- und -zimtsäurederivate
US5466861A (en) * 1992-11-25 1995-11-14 Sri International Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
FI990180A7 (fi) * 1996-08-12 1999-03-08 Celgene Corp Uusia immunoterapeuttisia aineita ja niiden käyttö sytokiini-tasojen pienentämiseksi
AU4849199A (en) 1998-07-01 2000-01-24 Celgro Fungal growth inhibitors
SE0102320D0 (sv) * 2001-06-27 2001-06-27 Ingvar Brandt Novel treatment of adrenocortical hypersecretion and tumour growth
MXPA05009434A (es) 2003-03-05 2005-11-23 Celgene Corp Compuestos de difeniletileno y usos de los mismos.
US7470723B2 (en) 2003-03-05 2008-12-30 Celgene Corporation Diphenylethylene compounds and uses thereof

Similar Documents

Publication Publication Date Title
AR040803A1 (es) Ligandos de receptores canabinoides, composiciones farmaceuticas, un proceso para su elaboracion y el uso de dichos compuestos, solos o combinados, para la preparacion de medicamentos
JP2008512378A5 (cg-RX-API-DMAC7.html)
RU98123097A (ru) Карбоксамиды бензофурана и их терапевтическое применение
KR100783835B1 (ko) 면역억제제로서 5-(벤즈-(z)-일리덴-티아졸리딘-4-원유도체
US7425552B2 (en) Pyridazinone compounds
JP2018150331A5 (cg-RX-API-DMAC7.html)
US7462611B2 (en) Pyrro[1,2-b]pyridazinone compounds
JP2006510676A5 (cg-RX-API-DMAC7.html)
US7741348B2 (en) Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds
ES2330636T3 (es) Derivados amida del acido 3-oxo-1,3-dihidro-indazol-2-carboxilico como inhibidores de la fosfolipasa.
US20060135575A1 (en) 2-Acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
RU2007116861A (ru) P13-киназы
UA73553C2 (en) Piperazine derivatives
AU2005271130A1 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
JP2007524707A5 (cg-RX-API-DMAC7.html)
JP2004526711A5 (cg-RX-API-DMAC7.html)
JP2007524704A5 (cg-RX-API-DMAC7.html)
EP0589985A1 (en) 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract
RU99112569A (ru) Бициклические арильные карбоксамиды и их терапевтическое применение
RU2400472C2 (ru) Производные арилалкилкарбаматов, их получение и их применение в терапии
JP2019501927A5 (cg-RX-API-DMAC7.html)
JP2007507474A5 (cg-RX-API-DMAC7.html)
JP2013526610A5 (cg-RX-API-DMAC7.html)
PT1406899E (pt) Derivados de fenilacetamido-tiazole, processo para a sua preparação e a sua utilização como agentes antitumorais
US7834009B2 (en) 4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds